This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. Terrence Coyle, MD
Bellevue, Wash

Arch Ophthalmol. 1994;112(10):1274.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Four percent of the white population in the United States are color blind. Is that figure of clinical value? Not really, just as might be the case for the Optic Neuritis Treatment Trial (ONTT) study.¹ One cannot lump statistics when the incidence of a condition is different for men and women. Four percent of the population are color blind, but if we split it up by gender, 7% are men and 1% are women. My analogy is unfair because color blindness is sexlinked, but nonetheless, combining statistics derived from men and women for many autoimmune diseases results in unreliable data. The prognosis for optic neuritis is more than twice as bad for women. Approximately 34% of the men and 75% of the women with idiopathic optic neuritis will manifest multiple sclerosis (MS) within 15 years.² An analysis of the benefits of intravenous steroids requires comparisons of control white . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?